Xtant Medical Holdings, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
AMEX
Xtant Medical Holdings, Inc. announced the appointment of Abhinav Jain, an analyst from significant shareholder Nantahala Capital Management, to its Board of Directors.
AMEX
SCHEDULE 13D: Nantahala Capital Significantly Boosts Stake in Xtant Medical, Acquiring Nearly Half of Outstanding Shares
Nantahala Capital Management and its affiliated funds have acquired a substantial block of Xtant Medical Holdings, Inc. common stock, increasing their beneficial ownership to 49.1% of the company.
AMEX
SCHEDULE 13D/A: OrbiMed Entities Divest Entire Stake in Xtant Medical Holdings, Cease to Be 5% Beneficial Owners
OrbiMed Advisors LLC and OrbiMed ROF II LLC have filed an exit Schedule 13D/A, reporting the sale of their entire beneficial ownership in Xtant Medical Holdings, Inc., reducing their stake to 0%.